Inotuzumab ozogamicin

Besponsa®

1mg prašak za koncentrat za rastvor za infuzijuSerbiaAuthorisedAuthorised 15 Jun 2022

In other countries

The same active substances on other registers, the same brand first.

BesponsaBrazil · Pfizer Brasil LtdaSame brand
BesponsaCanada · 0.9 MG / VIAL · Powder For Solution · Pfizer Canada UlcSame brand
Besponsa 1 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 1 mg · polvo para concentrado para solución para perfusión · Pfizer Europe Ma EeigSame brand
BesponsaEuropean Union · Pfizer Europe MA EEIGSame brand
BesponsaCroatiaSame brand
BesponsaItaly · polvere per concentrato e soluzione per soluzione per infusione · Pfizer Europe Ma EeigSame brand
Besponsa 1 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Pfizer Europe MA EEIGSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

BesponsaNew Zealand · Inj 1 mg vial

BESPONSA 1 mgRomania · 1mg · pulb. pt. conc. pt. sol. perf. · Pfizer Europe Ma Eeig

BESPONSA 0.9 mg VialSaudi Arabia · Wyeth

Besponsa Powder for Concentrate for Solution for Infusion 1MG/VialSingapore · 1mg/vial · powder, for solution · Pfizer Private Limited

BesponsaUnited States · 0.9/MG/VIAL · powder, for injection solution, lyophilized powder · Wyeth Pharms INC

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl) sodl · Added 9 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Inotuzumab ozogamicin
Strength: 1mg
Dosage form: prašak za koncentrat za rastvor za infuziju
Route: parenteralno
Register: Serbia (ALIMS)
Status: Authorised
Status in the register: REGISTRACIJA
Authorised: 15 Jun 2022
Registration: 495966
Marketing authorisation holder: Pfizer SRB D.O.O.
Manufacturer: PFIZER SERVICE COMPANY BV - Belgija
ATC code: L01FB01
Group: Antineoplastic and immunomodulating agents
Procedure: Humani lekovi
Supply: SZ